Farnum Rhonda sold TBPH

March 16, 2026 · Form 4 insider transaction

Farnum Rhonda sold 15,534 shares of Theravance Biopharma, Inc. at $14.00 per share, a transaction worth $217.5K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
15,534
Price
$14.00
Total value
$217.5K
RoleOfficer
SecurityOrdinary Shares
Transaction codeS: Open-market sale
Transaction dateMarch 16, 2026
Filing dateMarch 18, 2026
Shares owned after240,465
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR